iqvia semaglutide tirzepatide prescriptions us q3 2024 Non-Traditional Channels: The Compounded GLP-1 Market Obesity Deep Dive: The Unparalleled

Semaglutide has become one of the most widely used GLP-1 receptor agonists for weight loss, but questions about side effects remain common among prospective patients

Retatrutide is often called a triple agonist because it activates three hormone receptor pathways: GLP-1 (involved in appetite, satiety, and glucose regulation), GIP (involved in insulin response and metabolic signaling), and glucagon (involved in energy expenditure and fat metabolism)

Semaglutide starts to come off patent in many countries from 2026

& Korsching, S

however, eating smaller portions means consuming fewer total calories, so some patients may develop micronutrient deficiencies if they don't eat balanced meals or supplement appropriately